Moxidectin Oral (Chanelle) 1 mg/ml Oral Solution for Sheep

País: Reino Unido

Língua: inglês

Origem: VMD (Veterinary Medicines Directorate)

Ingredientes ativos:

Moxidectin

Disponível em:

Chanelle Pharmaceuticals Manufacturing Ltd

Código ATC:

QP54AB02

DCI (Denominação Comum Internacional):

Moxidectin

Forma farmacêutica:

Oral solution

Tipo de prescrição:

POM-VPS -Prescription Only Medicine – Veterinarian, Pharmacist, Suitably Qualified Person

Grupo terapêutico:

Sheep

Área terapêutica:

Endectocide

Status de autorização:

Authorized

Data de autorização:

2018-05-14

Características técnicas

Unlimited renewal: August 2022
AN: 01156/2022
Page 1 of 8
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Moxidectin Oral (Chanelle) 1 mg/ml oral solution for sheep
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
One ml contains:
ACTIVE SUBSTANCE:
Moxidectin
1.00 mg
EXCIPIENT:
Benzyl Alcohol (E1519)
40.0 mg
For the full list of excipients, see section 6.1
3.
PHARMACEUTICAL FORM
Oral solution
Clear colourless to yellowish solution
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Sheep.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment and prevention of mixed infections of sheep with
parasites
sensitive to moxidectin
Adult and/or immature gastro-intestinal nematodes:
- _Haemonchus contortus _(including inhibited larvae)
- _Teladorsagia circumcincta _(including inhibited larvae)
- _Teladorsagia trifurcata_
- _Trichostrongylus axei _(including inhibited larvae)
- _Trichostrongylus colubriformis_
- _Trichostrongylus vitrinus_
- _Nematodirus battus_
- _Nematodirus spathiger_
Unlimited renewal: August 2022
AN: 01156/2022
Page 2 of 8
- _Nematodirus filicolis _(adults only)
- _Strongyloides papillosus _(larval stages only)
- _Cooperia curticei _(adults only)
- _Cooperia oncophora_
- _Oesophagostomum columbianum_
- _Oesophagostomum venulosum _(adults only)
- _Chabertia ovina_
- _Trichuris ovis _(adults only)
Adult respiratory tract nematode:
- _Dictyocaulus filaria_
The product has a persistent effect in preventing reinfection:
for 5 weeks by _Teladorsagia circumcincta _and _Haemonchus contortus_
for 4 weeks by _Oesophagostomum columbianum_
Clinical trials, after experimental and natural infection, have shown
that the
product is effective against certain benzimidazole resistant strains
of:
_Haemonchus contortus_
_Teladorsagia circumcincta_
_Trichostrongylus colubriformis_
_Cooperia curticei_
4.3
CONTRAINDICATIONS
Do not use in cases of known hypersensitivity to the active substance
or to any
of the excipients.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Care should be taken to a